Trial intelligence / Profile preview

Liqihuoxue Diwan for Chronic Stable Angina

ChiCTR-OIC-16008797Phase 4Recruiting

Sponsor
Shanghai Changzheng Hospital
Start
Jul 2015
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of liqihuoxue diwan in coronary arteriosclerosis and angina pectoris, sponsored by Shanghai Changzheng Hospital. Primary endpoint: Safety. Started Jul 2015; status: recruiting.

02

Drugs

liqihuoxue diwan
03

Conditions

coronary arteriosclerosisangina pectoris

Beyond the preview

Go deeper on ChiCTR-OIC-16008797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OIC-16008797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call